Navigation Links
AbbVie Named to S&P 500 Dividend Aristocrat Index
Date:1/21/2013

NORTH CHICAGO, Ill., Jan. 21, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, has been named to the S&P 500 Dividend Aristocrat Index for 2013.

The Dividend Aristocrat Index measures the performance of dividend-paying companies within the S&P 500 Index that have followed a policy of increasing dividends each year for at least 25 consecutive years.  In 2013, only 54 companies, approximately 11 percent of companies named to the S&P 500 Index, were included in this year's update. 

"AbbVie is honored to be included among the premier dividend-paying companies which are represented by this Index," said Bill Chase , executive vice president and chief financial officer, AbbVie. "AbbVie is committed to delivering attractive shareholder returns through a strong and sustainable dividend which we intend to grow in the future."

AbbVie was included as a result of the Index's change in its treatment of spin-off companies.  AbbVie was also named to the S&P High Yield Dividend Aristocrats Index, which measures the performance of companies within the S&P Composite 1500 that have followed a policy of increasing dividends each year for at least 20 consecutive years.

About AbbVie

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. With its 125-year history, the company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. In 2013, AbbVie employs approximately 21,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit

SOURCE AbbVie
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Roche Diagnostics Named to FORTUNE magazines 2013 list of "100 Best Companies to Work For"
2. Ferring Pharmaceuticals Inc. Named 10th Fastest Growing New Jersey Company
3. Kareo Named a Top Workplace by the Orange County Register
4. Jack Cochran, MD, Executive Director of The Permanente Federation at Kaiser Permanente, named to National Quality Forum Board
5. MRI Interventions Named 2012 Global Company of the Year in Image-Guided Neural Interventions
6. MEI Pharmas Mitochondrial Inhibitor Drug Candidate ME-344 Named One of Top 10 Oncology Products for 2012
7. CardioMEMS Named as a Finalist for Intel Innovation Award
8. Building on a Legacy: Vinita Gupta, CEO of Lupin Pharmaceuticals, Inc., Named Ernst & Young U.S. 2012 Family Business Award of Excellence winner
9. West Virginia Rx Program Named a Mutual of America 2012 Community Partnership Award Winner
10. Vasomedical Named on Deloittes 2012 Technology Fast 500 List
11. Kimberly Ezdebski Named an ASQ-Certified Manager of Quality/Organizational Excellence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... SAN DIEGO , July 31, 2015 ... Eisai Co., Ltd. (Headquarters: Tokyo , ... Halozyme Therapeutics, Inc. (Headquarters: San Diego, California ... , "NASDAQ: HALO") have signed a clinical collaboration agreement ... , "eribulin") in combination with Halozyme,s investigational drug PEGPH20 ...
(Date:7/31/2015)... July 31, 2015 Magnaquest, ... video, data and cloud computing operators has signed ... pharma giant for Internet of Things (IoT) related ... offered on subscription model.      (Logo: ... is striving for business innovations to make healthcare ...
(Date:7/30/2015)... DIEGO , July 30, 2015 /PRNewswire/ ... it has signed a definitive agreement to ... of non-invasive ventilation and sleep-disordered breathing medical ... clinical, innovation and market reputation in China, combined with ResMed,s global leadership in ... people in China ...
Breaking Medicine Technology:Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3
... N.J. , May 11 Nearly one-third ... alone, and not in combination with other asthma control ... Drug Administration (FDA) on the risk of worsening asthma ... to a new study from the Medco Research ...
... The DNA Medicine Institute announced today that it has received a ... Gates Foundation.  The grant will support an innovative global health research project ... for Malaria." , , , ... project is one of 78 grants announced by the Gates Foundation in ...
Cached Medicine Technology:Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations 2Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations 3Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations 4Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations 5DNA Medicine Institute Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research 2DNA Medicine Institute Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research 3
(Date:8/1/2015)... ... 2015 , ... On March 19, 2015 Phil Valentine – the Executive Director of Connecticut Community ... by stepping off Springer Mountain and heading north. Since that day, Phil has hiked ... and was greeted by friends and family. He visited CCAR and left an inspirational ...
(Date:7/31/2015)... NV (PRWEB) , ... July 31, 2015 , ... Ticket Down is a reputable source ... at the MGM Grand Garden Arena. Fans of every genre of music will have ... September 18th, the first day of the festival, the following artists will perform: Sam ...
(Date:7/31/2015)... ... August 01, 2015 , ... The Honor Society of Nursing, Sigma Theta ... Future of Nursing (GAPFON) 20-21 July 2015 in San Juan, Puerto Rico. Key nurse ... , Dr. Silvia Cassiani, Advisor, Nursing and Allied Health Personnel Development, Unit of Human ...
(Date:7/31/2015)... ... 31, 2015 , ... Ticket Down is a reliable source for authentic tickets ... Grant Park. The festival will end on Sunday, August 2nd. , ... annual Lollapalooza. This unique and unbelievably popular festival attracts the best in entertainment ...
(Date:7/31/2015)... ... 2015 , ... Recently touted by Becker’s Healthcare as one ... , Jvion continues to disrupt the predictive analytic and big data market using ... population level illness to drive prevention and better health outcomes. Most recently, Jvion ...
Breaking Medicine News(10 mins):Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2
... heavily may experience more chronic musculoskeletal pain, suggests a new ... 6,000 Kentucky women over the age of 18 were surveyed ... included in the analysis were fibromyalgia, sciatica, chronic neck pain, ... and pain all over the body. Results showed that ...
... reasons it is important to be able to identify farm ... generally been marked by branding with hot irons or by ... identified by the implant of a microchip transponder. Horses ... towards the use of microchips. Branding is still permitted ...
... InterCure Ltd., a medical device company publicly traded on ... European Journal of Heart Failure, a peer ... published the results of a 72-patients, randomized, controlled study ... at the home setting can significantly relieve symptoms of ...
... At the Oct. 2-6 microTAS 2011 conference, the ... nanotechnology and detection technologies for life science and ... simple, low-cost, method for separating and safely collecting ... The research results resolve the critical technical challenge ...
... an advance toward a much-needed early diagnostic test for Alzheimer,s ... develop AD have high blood levels of a protein linked ... ACS, Journal of Proteome Research. Theo Luider ... already have AD, and the numbers are rising with the ...
... an attractive class of drug candidates because of their ... effects. Dr. Andrei Yudin, Professor, Department of Chemistry, ... process that makes linear peptides circular, which allows these ... increase their stability compared to linear peptides. ...
Cached Medicine News:Health News:Study shows link between smoking and chronic pain in women 2Health News:The mark of the beast: tradition or stress? 2Health News:European Journal of Heart Failure publishes new randomized controlled clinical study of RESPeRATE 2Health News:New UC research promises better collection of prostate cancer cells 2Health News:New UC research promises better collection of prostate cancer cells 3Health News:OGI and MaRS Innovation invest in peptide therapeutics 2
... a patented Per-fit™ flexible PVC tube with ... cuff specifically designed to reduce insertion force ... anatomy. The kit s unique obturator/dilator design ... allowing for an easier transition through the ...
... Per-fit™ flexible PVC tube with a tapered ... designed to reduce insertion force and more ... kit s unique obturator/dilator design is engineered ... an easier transition through the tissue into ...
... Self-contained kits provide convenience and cost ... tracheostomy care trays offer a variety of ... and management of the tracheostomized patient. , ... trays, and trays with disposable inner cannula ...
... and cost control. , ,Our full ... variety of wound dressing components for the ... patient. , ,Tray configurations include full ... inner cannula for both rigid and flexible ...
Medicine Products: